Content hub
Data-driven, High Impact Solutions for Biotech
Solution packages and strategic services built specifically for biotechs: the best data, streamlined tools, and expert guidance for wherever you are in your journey
Flexible biotech packages for every stage
Discover how to reduce risk, accelerate progress, and make smarter decisions at every step.
Pre-IND
Accelerator
Accelerate Your IND Approval
- Data-driven IND strategy
- Robust protocol & clinical planning
- Reduced regulatory back-and-forth
- Tailored to your asset & budget
- Expert SME guidance
Clinical Planning
& Study Start-up
Accelerate Your IND Approval
- Data-driven IND strategy
- Robust protocol & clinical planning
- Reduced regulatory back-and-forth
- Tailored to your asset & budget
- Expert SME guidance
Clinical Strategy
& Validation
Accelerate Your IND Approval
- Data-driven IND strategy
- Robust protocol & clinical planning
- Reduced regulatory back-and-forth
- Tailored to your asset & budget
- Expert SME guidance
Podcast: Small biotechs, big decisions
Small Biotechs, Big Decisions is a limited podcast series exploring the challenges and opportunities facing emerging biotech companies today. Hosted by Daniel Chancellor, VP, Thought Leadership, Norstella and Claire Riches, VP, Clinical Solutions, Citeline, each episode shares the truth about the current biotech landscape covering market dynamics, regulatory shifts, and strategic decisions to help biotech leaders navigate uncertainties and drive innovation.
Watch the video series
Each episode begins with a 1-minute highlight and continues into a full discussion of strategic insights for biotech leaders. Click “learn more” for expert guidance, key takeaways, and actionable advice.
First Sparks Falling for Innovation in a Harsh Market
Strategies to Secure Critical Biotech Funding Amid Market Challenges
How to crush competitive threats and stand out in biotech
Master Regulatory Hurdles and Accelerate Your Drug Development
Drive Early CRO Engagement to Optimize Funding, Trial Design, and Recruitment in Biotech
Coming Soon
Winning Biotech Investors Through Strategic Partnerships and Trial Innovation
Claire Riches, VP, Clinical Solutions, Citeline
Claire Riches brings over 25 years of pharma experience to help biotech teams run faster, smarter trials. At Citeline, she leads with deep expertise in clinical research, commercial strategy, and therapeutic leadership, turning complex data into clear, AI-driven clinical solutions. Claire is passionate about using data and AI to drive better decisions particularly in patient recruitment, trial diversity, and increasing the chances of success.
Daniel Chancellor, VP, Thought Leadership, Norstella
Daniel has more than 15 years of experience in the biopharma industry, spanning roles in drug discovery, market analysis, competitive intelligence, and strategic consulting. Beginning his advisory career at Citeline, Daniel now oversees the thought leadership program for Norstella and its constituent companies, producing unique research that guides clients through ever-changing industry dynamics. He regularly participates in webinars and conferences providing expert insights across leading industry publications.
Extensive Data & Technology Foundation, Augmented With Expert Advice
Unlike fragmented tools or one-size-fits-all providers, we offer depth, flexibility, and real partnership — tailored to the stage, strategy, and goals of our clients. From protocol design to site strategy, we streamline key steps so you can make smarter decisions, faster than ever.
Your accelerated path to biotech success begins here.
Partner with us for bespoke strategic expertise built around your goals, your timeline, and your budget.
At Citeline and Evaluate, we deliver trusted clinical and commercial intelligence with expert support, helping you move faster and make smarter decisions.
Resources
Catch up on Expert Webinars
Ready to see how Evaluate can help you make smarter decisions?
Get in touch with our team to explore the right solutions for your business.